Moxifloxacin 400 MG Oral Tablet — RxCUI 311787
RxNorm drug concept · Semantic clinical drug
RxCUI 311787
Semantic clinical drug · SCD
● Current RxNorm concept 24 FDA products
38 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311787
Official nameMoxifloxacin 400 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmoxifloxacin (as moxifloxacin HCl) 400 MG Oral Tablet; moxifloxacin HCl 400 MG Oral Tablet
FDA products mapped24
Package NDCs mapped38
Reported Medicaid activity (SDUD)36,008 prescriptions · 43 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Moxifloxacin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is an antibiotic for certain bacterial infections. As tablets or an IV, it treats pneumonia, skin infections, abdominal infections, sinus infections, bronchitis flare-ups and pl...
- Take them once a day, with or without food. Keep them at least 4 hours before or 8 hours after antacids, iron, or multivitamins, because those can block absorption. Finish the cour...
- How should I take my moxifloxacin tablets?
- Nausea, diarrhea, headache and dizziness are the most common. Those are usually manageable. Call your doctor if you have severe or watery diarrhea, or any symptoms that worry you.
🕸️ Concept Web — How Moxifloxacin 400 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Moxifloxacin 400 MG Oral Tablet
RxCUI 311787 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Moxifloxacin
139462IN
-
Moxifloxacin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Avelox
261456BN
-
Avelox
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Moxifloxacin Oral Tablet
374619SCDF -
Moxifloxacin Oral Product
1157858SCDG -
Moxifloxacin Pill
1157859SCDG -
Moxifloxacin Oral Tablet [Avelox]
368210SBDF -
Avelox Oral Product
1175685SBDG -
Avelox Pill
1175686SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Moxifloxacin Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Moxifloxacin 400 MG
330383SCDC -
Moxifloxacin 400 MG Oral Tablet [Avelox]
261339SBD -
Moxifloxacin 400 MG [Avelox]
574559SBDC
-
Moxifloxacin 400 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Moxifloxacin 400 MG
SCDC · 330383 -
Moxifloxacin Oral Tablet
SCDF · 374619 -
Moxifloxacin Oral Product
SCDG · 1157858 -
Moxifloxacin Pill
SCDG · 1157859
Brand-Name Concepts
-
Moxifloxacin 400 MG Oral Tablet [Avelox]
SBD · 261339 -
Moxifloxacin 400 MG [Avelox]
SBDC · 574559 -
Moxifloxacin Oral Tablet [Avelox]
SBDF · 368210 -
Avelox Oral Product
SBDG · 1175685 -
Avelox Pill
SBDG · 1175686 -
Avelox
BN · 261456
📦 FDA Products & Package NDCs
24 products · 38 package NDCs
38 package NDCs map to RxCUI 311787 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00904-7407-04 | 30 BLISTER PACK in 1 CARTON (0904-7407-04) / 1 TABLET, FILM... | MOXIFLOXACIN HYDROCHLORIDE | Major Pharmaceuticals | 2024-03-08 |
| 00904-7407-06 | 50 BLISTER PACK in 1 CARTON (0904-7407-06) / 1 TABLET, FILM... | MOXIFLOXACIN HYDROCHLORIDE | Major Pharmaceuticals | 2024-03-08 |
| 31722-0845-05 | 500 TABLET, FILM COATED in 1 BOTTLE (31722-845-05) | Moxifloxacin | Camber Pharmaceuticals, Inc. | 2023-03-02 |
| 31722-0845-30 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-845-30) | Moxifloxacin | Camber Pharmaceuticals, Inc. | 2023-03-02 |
| 33342-0322-07 | 30 TABLET, FILM COATED in 1 BOTTLE (33342-322-07) | Moxifloxacin | Macleods Pharmaceuticals Limited | 2026-03-02 |
| 33342-0322-12 | 10 BLISTER PACK in 1 CARTON (33342-322-12) / 10 TABLET, FIL... | Moxifloxacin | Macleods Pharmaceuticals Limited | 2026-03-02 |
| 50090-6609-00 | 10 TABLET, FILM COATED in 1 BOTTLE (50090-6609-0) | Moxifloxacin Hydrochloride | A-S Medication Solutions | 2023-08-23 |
| 50090-6609-01 | 7 TABLET, FILM COATED in 1 BOTTLE (50090-6609-1) | Moxifloxacin Hydrochloride | A-S Medication Solutions | 2023-10-31 |
| 50090-7244-01 | 7 TABLET, FILM COATED in 1 BOTTLE (50090-7244-1) | MOXIFLOXACIN HYDROCHLORIDE | A-S Medication Solutions | 2024-09-13 |
| 50090-7665-00 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-7665-0) | Moxifloxacin Hydrochloride | A-S Medication Solutions | 2025-10-01 |
| 50268-0576-13 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-576-13) / 1 TABL... | Moxifloxacin Hydrochloride | AvPAK | 2016-07-22 |
| 55111-0112-01 | 100 TABLET, FILM COATED in 1 BOTTLE (55111-112-01) | Moxifloxacin | Dr. Reddy's Laboratories Limited | 2014-03-05 |
| 55111-0112-05 | 500 TABLET, FILM COATED in 1 BOTTLE (55111-112-05) | Moxifloxacin | Dr. Reddy's Laboratories Limited | 2014-03-05 |
| 55111-0112-30 | 30 TABLET, FILM COATED in 1 BOTTLE (55111-112-30) | Moxifloxacin | Dr. Reddy's Laboratories Limited | 2014-03-05 |
| 55111-0112-66 | 5 BLISTER PACK in 1 CARTON (55111-112-66) / 10 TABLET, FILM... | Moxifloxacin | Dr. Reddy's Laboratories Limited | 2014-03-05 |
| 57237-0156-30 | 30 TABLET, FILM COATED in 1 BOTTLE (57237-156-30) | Moxifloxacin Hydrochloride | Rising Pharma Holdings, Inc. | 2014-03-04 |
| 63629-8357-01 | 7 TABLET, FILM COATED in 1 BOTTLE (63629-8357-1) | Moxifloxacin | Bryant Ranch Prepack | 2020-09-17 |
| 63629-8357-02 | 10 TABLET, FILM COATED in 1 BOTTLE (63629-8357-2) | Moxifloxacin | Bryant Ranch Prepack | 2020-11-05 |
| 65862-0603-30 | 30 TABLET, FILM COATED in 1 BOTTLE (65862-603-30) | MOXIFLOXACIN HYDROCHLORIDE | Aurobindo Pharma Limited | 2014-03-04 |
| 65862-0603-55 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (65862-603-55) / 1 TABL... | MOXIFLOXACIN HYDROCHLORIDE | Aurobindo Pharma Limited | 2014-03-04 |
| 65862-0603-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (65862-603-99) | MOXIFLOXACIN HYDROCHLORIDE | Aurobindo Pharma Limited | 2014-03-04 |
| 68084-0722-65 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-722-65) / 1 TABL... | Moxifloxacin Hydrochloride | American Health Packaging | 2014-03-19 |
| 70518-3738-00 | 7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3738-0) | MOXIFLOXACIN HYDROCHLORIDE | REMEDYREPACK INC. | 2023-05-30 |
| 70518-4312-00 | 7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-4312-0) | Moxifloxacin Hydrochloride Tablets, 400 mg | REMEDYREPACK INC. | 2025-03-18 |
| 70518-4458-00 | 7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-4458-0) | Moxifloxacin Hydrochloride | REMEDYREPACK INC. | 2025-08-27 |
| 71335-2329-01 | 7 TABLET, FILM COATED in 1 BOTTLE (71335-2329-1) | MOXIFLOXACIN HYDROCHLORIDE | Bryant Ranch Prepack | 2024-10-04 |
| 71335-2329-02 | 10 TABLET, FILM COATED in 1 BOTTLE (71335-2329-2) | MOXIFLOXACIN HYDROCHLORIDE | Bryant Ranch Prepack | 2024-01-03 |
| 71335-2815-01 | 7 TABLET, FILM COATED in 1 BOTTLE (71335-2815-1) | Moxifloxacin Hydrochloride | Bryant Ranch Prepack | 2025-10-15 |
| 71335-2815-02 | 10 TABLET, FILM COATED in 1 BOTTLE (71335-2815-2) | Moxifloxacin Hydrochloride | Bryant Ranch Prepack | 2025-10-15 |
| 72205-0001-05 | 500 TABLET, FILM COATED in 1 BOTTLE (72205-001-05) | Moxifloxacin Hydrochloride Tablets, 400 mg | Novadoz Pharmaceuticals LLC | 2019-04-16 |
| 72205-0001-30 | 30 TABLET, FILM COATED in 1 BOTTLE (72205-001-30) | Moxifloxacin Hydrochloride Tablets, 400 mg | Novadoz Pharmaceuticals LLC | 2019-04-16 |
| 72205-0001-31 | 50 BLISTER PACK in 1 CARTON (72205-001-31) / 10 TABLET, FIL... | Moxifloxacin Hydrochloride Tablets, 400 mg | Novadoz Pharmaceuticals LLC | 2019-04-16 |
| 72789-0037-10 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-037-10) | MOXIFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2020-02-17 |
| 72789-0038-10 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-038-10) | MOXIFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2019-12-10 |
| 72789-0080-10 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-080-10) | Moxifloxacin Hydrochloride Tablets, 400 mg | PD-Rx Pharmaceuticals, Inc. | 2020-04-10 |
| 72789-0233-10 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-233-10) | Moxifloxacin | PD-Rx Pharmaceuticals, Inc. | 2022-02-15 |
| 72789-0350-10 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-350-10) | Moxifloxacin Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2023-09-15 |
| 73473-0903-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (73473-903-30) | Moxifloxacin | Solaris Pharma Corporation | 2025-12-12 |
Observed labelers:
Bryant Ranch Prepack (6) ·
PD-Rx Pharmaceuticals, Inc. (5) ·
A-S Medication Solutions (4) ·
Dr. Reddy's Laboratories Limited (4) ·
Aurobindo Pharma Limited (3) ·
Novadoz Pharmaceuticals LLC (3)
· +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.